Chinese AI Startup Brings Diabetes Prediction to Shanghai Hospital

Leading Chinese AI startup 4Paradigm has announced a strategic partnership with Shanghai's Ruijin Hospital on AI application in healthcare, especially chronic health conditions. The two today unveiled their first AI-backed diabetes prediction and management product, "Rui Ning Zhi Tang," which predicts diabetes and diabetic cardiovascular complications risk in the next three years and provides assessments and personalized solutions for disease prevention and control. Ruijin is one of the most highly reputed hospitals in China. Its Department of Endocrinology has topped national endocrinology rankings for eight consecutive years. Ruijin also leads the National Metabolic Clinical Research Center and the Key Laboratory of the Ministry of Health.